5-part hematology analyzers typically range from about 30,000–80,000 USD for new mid-range systems, with some regions and configurations pushing prices above 100,000 USD when advanced automation and AI-empowered morphology are included.

What is a 5-part hematology analyzer?

A 5-part hematology analyzer is an automated CBC (complete blood count) system that differentiates white blood cells into five subtypes: neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Compared with 3-part analyzers, it offers more granular leukocyte information, supporting better assessment of infection, allergy, and hematologic disorders.

Typical core capabilities include:

• 5-part WBC differential (NEU, LYM, MON, EOS, BAS).
• 20–30+ CBC parameters (RBC indices, platelets, histograms).
• Throughput often between 40–80 samples per hour.
• Automated sampling, dilution, and reagent handling.

This level of detail makes 5-part analyzers common in regional hospitals, diagnostic laboratories, and larger clinics that handle more complex cases than basic wellness screening.

5-part hematology analyzer price range

Pricing depends on region, brand positioning, automation level, and whether the system is bundled with consumables or service contracts.

Global benchmark price tiers

• Entry to mid-range 5-part systems: about 30,000–80,000 USD for most new devices sold into regional hospitals and diagnostic centers.
• Premium 5-part or AI-integrated systems: typically 60,000–100,000+ USD, especially when advanced morphology, high throughput, and strong automation are included.
• Refurbished or lower-cost units: can start from around 5,000–15,000 USD, with fewer features, older technology, or shorter warranties.

Regional examples:

• India: roughly 2,750–10,450 USD equivalent, driven by regional pricing and portfolio positioning.
• North America: often 50,000–120,000 USD for comparable systems, reflecting regulatory and service cost structures.

5-part vs 7-part and multi-functional systems

Modern analyzers increasingly blur the line between classic 5-part systems and higher-differential or multi-functional platforms.

A useful way to see the differences:

System type	WBC differentiation	Typical throughput (tests/hour)	Typical price band (USD)	Main users	Key strengths
3-part basic	LYM, MID, GRAN	20–60	5,000–25,000	Small clinics, basic labs	Lowest capital cost, simple workflow​
5-part mid-range	Standard 5-part	40–80	30,000–80,000	Hospitais regionais, centros de diagnóstico	Better clinical detail, proven technology
7-part premium	5-part + abnormal cells (e.g. NST, NSG, NSH, RET)	60-200+	80,000–150,000+	Grandes hospitais, laboratórios de referência	Advanced morphology, deeper clinical insight
7-part multi-functional (CBC + immunoassay + biochemistry)	7-part morphology + expanded panels	10-15	35,000–100,000	Mid- to large facilities optimizing space	Consolidates 3–4 analyzers into one, strong ROI

Ozelle’s 7-part AI-powered platforms (EHBT-50, EHBT-75) show how some devices deliver 7-part and multi-modal testing at price levels that historically belonged to high-end 5-part analyzers.

How Ozelle positions its AI hematology analyzers on price and value

AI-powered morphology at “5-part pricing”

Ozelle’s AI-driven analyzers use a 40-million-sample training database and WAIC-recognized algorithms to achieve 7-part differential and abnormal cell flagging at mid-range price points. This means facilities considering a classic 5-part analyzer can often access 7-part AI morphology with similar capital investment, especially with models like the EHBT-50 Mini Lab.

Key differentiators versus typical 5-part systems:

• Cell morphology imaging instead of traditional impedance-only measurement.
• Identification of additional cell types and states (e.g. NST, NSG, NSH, ALY, PAg, RET) that go beyond standard 5-part outputs.
• Integrated AI interpretation and report comments that support clinical decision-making.

More about Ozelle’s CBC solutions:

• AI-powered CBC solutions overview: https://ozellemed.com/en/cbc-analyzer-solution-ai-powered-hematology-for-hospitals-labs-clinics-ozelle/
• Hematology analyzer portfolio: https://ozellemed.com/en/hematology-analyzer-for-sale-transforming-diagnostic-capabilities-with-ai-powered-technology/

Estimated price positioning for Ozelle’s EHBT-50 Mini Lab

The EHBT-50 is a 7-differential, multi-functional analyzer integrating hematology, immunoassay, biochemistry, and basic urine/fecal testing in one compact device. Ozelle’s own pricing guide estimates that this type of system sits roughly in the 35,000–65,000 USD price band, depending on configuration and market.

Relevant details:

• Estimated EHBT-50 price: ~35,000–65,000 USD.
• Typical comparable capital cost if using three separate analyzers: 65,000–130,000 USD (CBC + immunoassay + chemistry), meaning the EHBT-50 can reduce upfront investment by about 40–70% while simplifying installation and training.
• Throughput: about 10 samples per hour, appropriate for mid-volume labs and clinics needing multi-parameter workups in a single run.

Product detail page on Ozelle’s site:

• EHBT-50 and related CBC pricing content: https://ozellemed.com/en/5-part-hematology-analyzer-price-complete-guide-to-costs-features-and-clinical-value/

Market-leading technical features that impact cost-effectiveness

Ozelle emphasizes features that directly affect real-world cost and efficiency rather than only headline price:

• All-in-one cartridge design: single-use cartridges combine reagents and waste containment, reducing maintenance, cross-contamination risk, and pipeline cleaning needs.
• Maintenance-free or low-maintenance operation: many Ozelle analyzers rely on dry-type QC cards and sealed kits, minimizing technician workload and downtime.
• Room-temperature storage for test kits, avoiding the cost and complexity of cold chain logistics.
• Smart IoT platform for fleet management, QC tracking, and remote support, which can lower total cost of ownership across distributed sites.

For facilities comparing 5-part analyzers purely on price, these design choices often translate into 40–60% lower total cost of ownership over 5 years when accounting for service, labor, and consumables.

5-part hematology analyzer price factors you should evaluate

When you evaluate the price of a 5-part analyzer—whether from Ozelle or another manufacturer—focus on the total diagnostic value per test, not just the sticker price.

Key factors:

• Throughput needs
  • 20–50 tests/day: smaller clinics; a compact 5-part or a mid-range AI system like EHBT-25/EHBT-50 may be sufficient.
  • 100–300+ tests/day: regional hospitals and central labs benefit from higher automation and integrated platforms.
• Automation and workflow
  • Autoloaders, closed-tube sampling, integrated QC, and minimal daily maintenance reduce hands-on time and total staffing cost.
  • Ozelle’s devices use guided touch interfaces and automated staining/mixing to shorten training and startup time.
• Diagnostic depth
  • Classic 5-part analyzers enumerate standard leukocyte subsets, but may not flag immature or dysplastic forms with the same clarity as AI morphology systems.
  • Systems like the EHBT-50 and EHBT-75 provide morphological images and abnormal flags (NST, NSH, etc.), which support early detection of complex conditions such as hematologic malignancy or severe infection.
• Consumable model
  • Per-test consumables for hematology typically range around 1–5 USD depending on brand and volume, with immunoassay or specialized tests costing more.
  • Single-use cartridges and room-temperature kits can cut waste and storage costs, particularly in multi-site networks.
• Service and integration
  • Consider LIS/HIS connectivity, remote diagnostics, and IoT-based device management when comparing quotes; these features can reduce IT integration costs and improve uptime.

FAQ: 5-part hematology analyzer price and Ozelle’s strengths

What is the typical price of a new 5-part hematology analyzer?

Most new 5-part analyzers for hospital and diagnostic lab use fall between 30,000 and 80,000 USD, with premium AI-enabled platforms reaching 60,000–100,000+ USD.

Why do some 5-part systems cost less than 20,000 USD?

Lower-priced models are often:

• Regionally priced for cost-sensitive markets.
• Limited in automation or throughput.
• Lacking advanced morphology, image review, or integrated immunoassay/chemistry.

They can be appropriate for lower-volume sites, but may not match the efficiency and diagnostic depth of mid- and high-end systems.

How does Ozelle’s EHBT-50 compare with a traditional 5-part analyzer on price?

The EHBT-50 is estimated around 35,000–65,000 USD, providing 7-part CBC, immunoassay, biochemistry, and basic urine/fecal testing in a single platform. Compared with buying separate CBC, chemistry, and immunoassay analyzers (often totaling 65,000–130,000 USD), this consolidates multiple investments into one device while maintaining lab-grade accuracy.

Can a 7-part AI analyzer replace a 5-part analyzer?

For many facilities, yes.

AI-powered 7-part systems like those from Ozelle deliver:

• All standard CBC and 5-part parameters.
• Additional abnormal cell detection and morphology images.
• Comparable or better per-test economics when considering consolidation and reduced manual review.

This is why Ozelle positions its analyzers as 7-part capability at 5-part price levels for many mid-range customers.

What ongoing costs should I expect besides the purchase price?

Ongoing costs usually include:

• Reagents and cartridges (per-test costs).
• Quality control materials.
• Preventive maintenance or extended service contracts.
• Occasional calibration or software updates.

Ozelle’s use of sealed, maintenance-free cartridges, room-temperature storage, and dry QC cards is designed to keep these recurring costs predictable and manageable.

Where can I learn more about Ozelle’s hematology and CBC pricing?

You can explore official content and product information on Ozelle’s website:

• 5-part hematology analyzer price guide (includes EHBT-50 positioning): https://ozellemed.com/en/5-part-hematology-analyzer-price-complete-guide-to-costs-features-and-clinical-value/
• Cell counter and hematology analyzer cost & ROI overview: https://ozellemed.com/en/cell-counter-price-complete-guide-to-hematology-analyzers-costs-and-roi-in-2025/
• CBC machine price and platform overview: https://ozellemed.com/en/complete-blood-cell-count-cbc-machine-price-a-comprehensive-guide-to-modern-hematology-analyzers/
• AI-powered CBC analyzer solutions for hospitals, labs, and clinics: https://ozellemed.com/en/cbc-analyzer-solution-ai-powered-hematology-for-hospitals-labs-clinics-ozelle/

These resources detail current pricing bands, technical specifications, and ROI examples tailored to different facility types.